Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (31-40 of 324) with videos related to

Pageof 33
Sort By:
AIDS Patient Care and Stds|February 16, 2006
Refusing HIV testing in an urgent care setting: results from the "Think HIV" programRebecca V Liddicoat, Elena Losina, Minhee Kang, et al.
Alcoholism, Clinical and Experimental Research|April 22, 2004
Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problemsJeffrey H Samet, Nicholas J Horton, Seville Meli, et al.
Journal of the International AIDS Society|January 20, 2022
Do not forget the children: a model-based analysis on the potential impact of COVID-19-associated interruptions in paediatric HIV prevention and careClare F Flanagan, Nicole McCann, John Stover, et al.
Antiviral Therapy|September 9, 2011
Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South AfricaJulie H Levison, Catherine Orrell, Elena Losina, et al.
Annals of Internal Medicine|March 10, 2020
Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness AnalysisRochelle P Walensky, Tim Horn, Nicole C McCann, et al.
Antiviral Therapy|July 7, 2009
HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programmeCatherine Orrell, Rochelle P Walensky, Elena Losina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and costCharles B Holmes, Hui Zheng, Neil A Martinson, et al.
Annals of Internal Medicine|September 14, 2020
Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure ProphylaxisRochelle P Walensky, Tim Horn, Nicole C McCann, et al.
Health Care Financing Review|February 10, 2007
Budget impact of Medicaid Section 1115 demonstrations for early HIV treatmentBruce R Schackman, Kenneth A Freedberg, Sue J Goldie, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 14, 2005
Optimal allocation of testing dollars: the example of HIV counseling, testing, and referralRochelle P Walensky, Milton C Weinstein, Heather E Smith, et al.
Pageof 33

Showing results (31-40 of 324) with videos related to

Sort By:
Pageof 33
AIDS Patient Care and Stds|February 16, 2006
Refusing HIV testing in an urgent care setting: results from the "Think HIV" programRebecca V Liddicoat, Elena Losina, Minhee Kang, et al.
Alcoholism, Clinical and Experimental Research|April 22, 2004
Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problemsJeffrey H Samet, Nicholas J Horton, Seville Meli, et al.
Journal of the International AIDS Society|January 20, 2022
Do not forget the children: a model-based analysis on the potential impact of COVID-19-associated interruptions in paediatric HIV prevention and careClare F Flanagan, Nicole McCann, John Stover, et al.
Antiviral Therapy|September 9, 2011
Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South AfricaJulie H Levison, Catherine Orrell, Elena Losina, et al.
Annals of Internal Medicine|March 10, 2020
Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness AnalysisRochelle P Walensky, Tim Horn, Nicole C McCann, et al.
Antiviral Therapy|July 7, 2009
HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programmeCatherine Orrell, Rochelle P Walensky, Elena Losina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and costCharles B Holmes, Hui Zheng, Neil A Martinson, et al.
Annals of Internal Medicine|September 14, 2020
Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure ProphylaxisRochelle P Walensky, Tim Horn, Nicole C McCann, et al.
Health Care Financing Review|February 10, 2007
Budget impact of Medicaid Section 1115 demonstrations for early HIV treatmentBruce R Schackman, Kenneth A Freedberg, Sue J Goldie, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 14, 2005
Optimal allocation of testing dollars: the example of HIV counseling, testing, and referralRochelle P Walensky, Milton C Weinstein, Heather E Smith, et al.
Pageof 33